Endo Reports Third Quarter 2015 Financial Results

Go back to Endo Reports Third Quarter 2015 Financial Results

Rationale for Endo (ENDP) Buyback 'Now Much Stronger', RBC Capital Says

November 6, 2015 8:30 AM EST

RBC Capital analyst Randall Stanicky lowered his price target on Endo International plc (NASDAQ: ENDP) to $91.00 (from $100.00) but maintained his Top Pick rating. The analyst said while the sell-off is hard to explain but rationale for buy-back is now much stronger.

On the weakness, the analyst pointed to several items: (i) the size of the write-down so soon after AUXL closed (1/29) (ii) the linkage to VRX and negative sector sentiment (iii) debate we heard around ability... More

Endo (ENDP) Tops Q3 EPS by 3c, Affirms FY Guidance

November 5, 2015 7:55 AM EST

Endo Int'l (NASDAQ: ENDP) reported Q3 EPS of $1.02, $0.03 better than the analyst estimate of $0.99. Revenue for the quarter came in at $746 million versus the consensus estimate of $736.16 million.

Endo sees FY2015 EPS of $4.50-$4.60, versus the consensus of $4.56. Endo Int'l sees FY2015 revenue of... More